Ma. Cugini et al., The effect of scaling and root planing on the clinical and microbiologicalparameters of periodontal diseases: 12-month results, J CLIN PER, 27(1), 2000, pp. 30-36
Background/aims: Previously, we reported that SRP resulted in a decrease in
mean pocket depth and attachment level and reduced prevalence and levels o
f Bacteroides forsythus, Porphyromonas gingivalis, and Treponema denticola
at 3 and 6 months post-SRP in 57 subjects with adult periodontitis. 32 of t
he 57 subjects were monitored at 9 and 12 months. Thus, the purpose of the
present investigation was to evaluate the microbial and clinical effects of
SRP in 32 (mean age 48+/-11) subjects over a 12-month period.
Method: Clinical assessments of plaque, gingival redness, suppuration, blee
ding on probing, pocket depth and attachment level were made prior to SRP a
nd at 3, 6, 9, and 12 months post-therapy. Subgingival plaque samples were
taken at each visit and analyzed using the checkerboard DNA-DNA hybridizati
on technique for the presence and levels of 40 subgingival species. Each su
bject also received maintenance scaling at each of the subsequent monitorin
g visits. Differences in clinical parameters and prevalence and levels of b
acterial species were analyzed pre- and post-therapy using the Wilcoxon sig
ned ranks test. The Quade test for related samples was used for analysis of
multiple visits.
Results: Mean pocket depth (mm+/-SEM) decreased from 3.2+/-0.3 at baseline
to 2.9+/-0.3 at 12 months (p<0.01). Mean attachment level showed significan
t reduction at 6 months, but did not diminish further. Bleeding on probing
and plaque were significantly reduced at 12 months (p<0.001, p<0.05, respec
tively). P. gingivalis, B. forsythus and T. denticola decreased in prevalen
ce and levels up to the 6-month visit and remained at these lower levels at
9 and 12 months. Significant increases in levels and prevalence were noted
at 12 months for Actinomyces naeslundii genospecies 2, Actinomyces odontol
yticus, Fusobacterium nucleatum as polymorphum, Streptococcus mitis, Capnoc
ytophaga sp, and Veillonella parvula.
Conclusions: The data suggest that the maintenance phase of therapy may be
essential in consolidating clinical and microbiological improvements achiev
ed as a result of initial therapy.